BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 17539254)

  • 1. Study of drug resistant cases among new pulmonary tuberculosis patients attending a tuberculosis center, Yangon, Myanmar.
    Aung WW; Ti T; Than KK; Thida M; Nyein MM; Htun YY; Maung W; Htun A
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):104-10. PubMed ID: 17539254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National anti-tuberculosis drug resistance survey, 2002, in Myanmar.
    Ti T; Lwin T; Mar TT; Maung W; Noe P; Htun A; Kluge HH; Wright A; Aziz MA; Paramasivan CN
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1111-6. PubMed ID: 17044203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-resistant tuberculosis in Yangon, Myanmar.
    Phyu S; Lwin T; Ti T; Maung W; Mar WW; Shein SS; Grewal HM
    Scand J Infect Dis; 2005; 37(11-12):846-51. PubMed ID: 16308219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistant tuberculosis in Estonia.
    Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
    Ani AE; Idoko J; Dalyop YB; Pitmang SL
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):67-71. PubMed ID: 18789463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
    Matee M; Mfinanga S; Holm-Hansen C
    APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
    Bercion R; Kuaban C
    Bull Soc Pathol Exot; 1998; 91(3):199-202. PubMed ID: 9773189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
    Al-Rubaish AM; Madania AA; Al-Muhanna FA
    Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence of resistance and risk factors for resistance in Mycobacterium tuberculosis. A retrospective study of 1,055 patients of a specialty hospital 1984 to 1993].
    Borchardt J; Kirsten D; Jörres R; Kroeger C; Magnussen H
    Pneumologie; 1996 Jan; 50(1):28-35. PubMed ID: 8774932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antituberculosis drug resistance and associated risk factors in the European section of Turkey.
    Karabay O; Otkun M; Akata F; Karlikaya C; Tuğrul M; Dündar V
    Indian J Chest Dis Allied Sci; 2004; 46(3):171-7. PubMed ID: 15553205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug susceptibility pattern of Mycobacterium tuberculosis isolates against conventional anti-tuberculosis drugs in Dhaka, Bangladesh.
    Mottalib A; Hossain M; Khalil I; Islam S; Hossain A
    Saudi Med J; 2011 May; 32(5):484-8. PubMed ID: 21556469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan.
    Javaid A; Hasan R; Zafar A; Ghafoor A; Pathan AJ; Rab A; Sadiq A; Akram CM; Burki I; Shah K; Ansari M; Rizvi N; Khan SU; Awan SR; Syed ZA; Iqbal ZH; Shaheen Z; ur Rehman N
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):326-31. PubMed ID: 18284840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.